Research & Publications
Dr. Seval is an Assistant Professor in Infectious Disease at Yale School of Medicine and Affiliated Faculty in the Yale Program in Addiction Medicine. He completed his undergraduate training at The University of Texas at Austin in Biochemistry and earned his MD from the Texas A&M Health Science Center College of Medicine. After completing his residency at New York Presbyterian Hospital/Columbia University, he stayed on for a year as faculty in the Department of General Internal Medicine practicing ambulatory care. Dr. Seval has been at Yale since 2017, initially for his T32 supported research fellowship under the mentorship of Dr. Sandra Springer, and joined the Infectious Disease faculty in 2020.
Dr. Seval is interested in the intersection of Infectious Diseases and addiction both as a clinician and clinical researcher. He serves as the Medical Director for Dr. Springer's NCATS funded RCT Project COMMIT, which compares integrated ID/addiction care with injectable buprenorphine versus treatment as usual for persons with OUD hospitalized with infections. He is the site PI for the multisite NIH funded RCT REPRIEVE, assessing the role of statins for primary prevention for people living with HIV. His clinical practice includes inpatient ID consultation at both the York St and St Raphael's campuses, and HIV primary care at the Nathan Smith Clinic.
Education & Training
- ResidencyNew York Presbyterian- Columbia (2016)
- MDTexas A&M Health Science Center (2013)